<code id='791F4ED74C'></code><style id='791F4ED74C'></style>
    • <acronym id='791F4ED74C'></acronym>
      <center id='791F4ED74C'><center id='791F4ED74C'><tfoot id='791F4ED74C'></tfoot></center><abbr id='791F4ED74C'><dir id='791F4ED74C'><tfoot id='791F4ED74C'></tfoot><noframes id='791F4ED74C'>

    • <optgroup id='791F4ED74C'><strike id='791F4ED74C'><sup id='791F4ED74C'></sup></strike><code id='791F4ED74C'></code></optgroup>
        1. <b id='791F4ED74C'><label id='791F4ED74C'><select id='791F4ED74C'><dt id='791F4ED74C'><span id='791F4ED74C'></span></dt></select></label></b><u id='791F4ED74C'></u>
          <i id='791F4ED74C'><strike id='791F4ED74C'><tt id='791F4ED74C'><pre id='791F4ED74C'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:1951
          A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT
          Joe Raedle/Getty Images

          During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

          But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

          advertisement

          The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Cardiologists urge adding sexual orientation, gender identity to health records
          Cardiologists urge adding sexual orientation, gender identity to health records

          AdobeTherearemoreopenlyLGBTQ+peopleintheU.S.thanever,butlittleisknownabouttheuniquehealthchallengest

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Pumping milk in bathrooms at health conferences is common

          AdobeEventhoughErinBoothwasnotthrilledabouthavingtotraveltoPhiladelphiaforaconferenceatsixweekspostp